No Data
BeiGene Highlights Waldenström's Macroglobulinemia Innovation at IWWM 2024
gtja: Bullish on innovative drugs policy, expected to continue to advance. Chinese patent medicine centralized procurement may face accelerated expansion.
With the support of the entire chain, innovative drugs have seen a series of bullish policies introduced in various regions, and favorable policies are expected to continue to advance in the future; centralized procurement of chinese patent medicine may accelerate its expansion.
Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks
Top Gap Ups and Downs on Monday: BLCO, SIRI, ICL, HMY and More
Shares of US-listed Chinese Stocks Are Trading Lower on Continued Weakness Amid Stimulus Uncertainty.
Hong Kong Stocks Fall on Uncertainty in Further Stimulus; Pharma Firms Lead Decline
No Data
No Data
